ARC Desk

Point of Care Testing Market is Heading Up 38.40 Billion US$ By 2026

Lehdistötiedote   •   Elo 20, 2019 09:40 EEST

The global Point of Care Testing Market Size was valued at USD 21.7 Billion in 2018 and is likely to rise up to USD 38.40 billion by 2026 growing at a CAGR of 7.4% from 2018 to 2026.

Market Overview:

Point of Care Testing Market 2018 - 2026 research report includes the SWOT analysis that's Strengths, Weakness, Opportunities and Threats which provides you complete analysis of competitors, market growth, market share and in addition as CAGR comparison by region. The report provides analysis of the global Point of Care Testing Market for the period from 2016 to 2026, wherein 2018–2026 is the forecast period and 2018 is the base year. Data for 2017 has been included as historical information.

The report covers all trends and technologies expected to play a major role in growth of the global Point of Care Testing Market during the forecast period. It highlights drivers, restraints, and opportunities expected to influence the market from 2018 to 2026. The study provides a holistic perspective on the Point of Care Testing Market, in terms of revenue (in US$ Mn) and volume (in million units), across different regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The report highlights key trends affecting the Point of Care Testing Market at the global level. Prominent countries/sub-regions covered in the report include the U.S., Canada, Germany, France, the U.K., Italy, Russia, India, China, Japan, South Korea, South East Asia, GCC, South Africa, and Brazil.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1136

The report comprises detailed ecosystem analysis, which provides a comprehensive view of the global Point of Care Testing Market. Porter’s five forces model has also been included to help understand the competition landscape of the market. Additionally, current indicators of diverse macro-economic factors are contextualized under key market indicators.

The report also analyzes the Point of Care Testing Market on the basis of various segments, with drug type being a prominent one. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Market Segmentation:

Market By Product

  • Glucose monitoring
    • Strips
    • Meters
    • Lancets
  • Cardiometabolic testing products
    • Cardiac marker testing products
    • Blood Gas/Electrolytes testing products
    • HBA1C testing products
  • Infectious disease testing products
    • Influenza testing products
    • HIV testing products
    • Hepatitis C testing products
    • Sexually Transmitted Disease (STD) testing products
    • Healthcare-Associated Infection (HAI) testing products
    • Respiratory infection testing products
    • Tropical disease testing products
    • Other infectious diseases testing products
  • Coagulation testing products
    • PT/INR testing products
    • Activated Clotting Time (ACT/APTT) testing products
  • Pregnancy and fertility testing products
    • Pregnancy testing products
    • Fertility testing products
  • Tumor/Cancer marker testing products
  • Urinalysis testing products
  • Cholesterol testing products
  • Hematology testing products
  • Drug-of-Abuse (DoA) testing products
  • Fecal occult testing products
  • Other products

Market By Technology

  • Lateral flow assays
  • Dipsticks
  • Microfluidics
  • Molecular diagnostics
  • Immunoassays
  • Agglutination assays
  • Flow-Through
  • Solid phase
  • Biosensors

Market By Prescription

  • OTC testing
  • Prescription-based testing

Market By Application

  • Cardio metabolic testing
  • Infectious disease testing
  • Nephrology testing
  • Drug-of-Abuse (DoA) testing
  • Blood glucose testing
  • Pregnancy testing
  • Cancer biomarker testing
  • Other applications

Market By End-user

  • Hospitals
  • Diagnostic centers
  • Research laboratories
  • Home-care settings
  • Other end-uses

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

Germany overwhelmed the Europe POC testing market and was esteemed around USD 1,718.4 million in the year 2018. In the Federal Republic of Germany, purpose of-care frameworks are progressively utilized inside hospitals and medical practices. Other therapeutic offices where point of care testing is generally utilized incorporates outpatient nursing care, drug stores and home visits. Along these lines, developing reception of point of care testing the country over will drive the provincial market development.

Japan POC testing market is anticipated to develop at a CAGR of 8.7% over the projection time frame. According to the measurements distributed by the World Health Organization (WHO), in excess of 20,000 individuals were experiencing HIV and tuberculosis in Japan in the year 2016. This rising rate animates the demand for point of care testing diagnostics tests bringing about developing demand and selection rate of point of care testing gadgets in the nation.

Market Participants / Key Players:

Few of the significant contributor in the global point of care industry are Abaxis, Abbott, Siemens AG, F. Hoffmann-La Roche Ltd., and Johnson and Johnson.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, internal and external proprietary databases, relevant patent and regulatory databases, national government documents, statistical databases, market reports, news articles, press releases, webcasts specific to companies operating in the market, national government documents, statistical databases, and Factiva.

Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews conducted for each market segment across geographies. ARC conducts primary interviews on an ongoing basis with market participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competition landscape, and market outlook. These help validate and strengthen secondary research findings. They also help develop the analysis team’s expertise and market understanding.

VIEW FULL RESEARCH REPORT@ https://www.acumenresearchandconsulting.com/point-of-care-testing-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Point of Care Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Point of Care Testing Market By Product
1.2.2.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Point of Care Testing Market Revenue Share By Product in 2017
1.2.2.3. Glucose monitoring
1.2.2.4. Cardiometabolic testing products
1.2.2.5. Infectious disease testing products
1.2.2.6. Coagulation testing products
1.2.2.7. Pregnancy and fertility testing products
1.2.2.8. Tumor/Cancer marker testing products
1.2.2.9. Urinalysis testing products
1.2.2.10. Cholesterol testing products
1.2.2.11. Hematology testing products
1.2.2.12. Drug-of-Abuse (DoA) testing products
1.2.2.13. Fecal occult testing products
1.2.2.14. Others
1.2.3. Point of Care Testing Market By Technology
1.2.3.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Point of Care Testing Market Revenue Share By Technology in 2017
1.2.3.3. Lateral flow assays
1.2.3.4. Dipsticks
1.2.3.5. Microfluidics
1.2.3.6. Molecular diagnostics
1.2.3.7. Immunoassays
1.2.3.8. Agglutination assays
1.2.3.9. Flow-Through
1.2.3.10. Solid phase
1.2.3.11. Biosensors
1.2.3.12. Others
1.2.4. Point of Care Testing Market By Prescription
1.2.4.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Prescription (2015-2026)
1.2.4.2. Global Point of Care Testing Market Revenue Share By Prescription in 2017
1.2.4.3. Otc Testing
1.2.4.4. Prescription-Based Testing
1.2.4.5. Others
1.2.5. Point of Care Testing Market By Application
1.2.5.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison BY APPLICATION (2015-2026)
1.2.5.2. Global Point of Care Testing Market Revenue Share BY APPLICATION in 2017
1.2.5.3. Cardio metabolic testing
1.2.5.4. Infectious disease testing
1.2.5.5. Nephrology testing
1.2.5.6. Drug-of-Abuse (DoA) testing
1.2.5.7. Blood glucose testing
1.2.5.8. Pregnancy testing
1.2.5.9. Cancer biomarker testing
1.2.5.10. Others
1.2.6. Point of Care Testing Market By End-user
1.2.6.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.6.2. Global Point of Care Testing Market Revenue Share By End-user in 2017
1.2.6.3. Hospitals
1.2.6.4. Diagnostic centers
1.2.6.5. Research laboratories
1.2.6.6. Home-care settings
1.2.6.7. Others
1.2.7. Point of Care Testing Market by Geography
1.2.7.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.7.2. North America Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.3. Europe Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.4. Asia-Pacific Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.5. Latin America Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.6. Middle East and Africa (MEA) Point of Care Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Cardio metabolic testing Production Date of Global Point of Care Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Point of Care Testing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Point of Care Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Point of Care Testing Major Manufacturers in 2017

CHAPTER 4. Point of Care Testing MARKET BY PRODUCT

4.1. Global Point of Care Testing Revenue By Product
4.2. Glucose monitoring
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Cardiometabolic testing products
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Infectious disease testing products
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Coagulation testing products
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Pregnancy and fertility testing products
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Tumor/Cancer marker testing products
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Urinalysis testing products
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Cholesterol testing products
4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Hematology testing products
4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Drug-of-Abuse (DoA) testing products
4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.12. Fecal occult testing products
4.12.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.12.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.13. Others
4.13.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.13.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Point of Care Testing MARKET By Technology

5.1. Global Point of Care Testing Revenue By Technology
5.2. Lateral flow assays
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Dipsticks
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Microfluidics
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Molecular diagnostics
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Immunoassays
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Agglutination assays
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Flow-Through
5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.9. Solid phase
5.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.10. Biosensors
5.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.11. Others
5.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Point of Care Testing MARKET By Prescription

6.1. Global Point of Care Testing Revenue By Prescription
6.2. Otc Testing
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Prescription-Based Testing
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Point of Care Testing MARKET BY APPLICATION

7.1. Global Point of Care Testing Revenue BY APPLICATION
7.2. Cardio metabolic testing
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Infectious disease testing
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Nephrology testing
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Drug-of-Abuse (DoA) testing
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Blood glucose testing
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Pregnancy testing
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.8. Cancer biomarker testing
7.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.9. Others
7.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. Point of Care Testing MARKET By End-user

8.1. Global Point of Care Testing Revenue By End-user
8.2. Hospitals
8.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.3. Diagnostic centers
8.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.4. Research laboratories
8.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.5. Home-care settings
8.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.6. Others
8.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 9. NORTH AMERICA Point of Care Testing MARKET BY COUNTRY

9.1. North America Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. North America Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. U.S.
9.3.1. U.S. Point of Care Testing Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4. Canada
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5. Mexico
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 10. EUROPE Point of Care Testing MARKET BY COUNTRY

10.1. Europe Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Europe Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. UK
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4. Germany
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5. France
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6. Spain
10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7. Rest of Europe
10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 11. ASIA-PACIFIC Point of Care Testing MARKET BY COUNTRY

11.1. Asia-Pacific Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Asia-Pacific Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. China
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4. Japan
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5. India
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.6. Australia
11.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.7. South Korea
11.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.8. Rest of Asia-Pacific
11.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 12. LATIN AMERICA Point of Care Testing MARKET BY COUNTRY

12.1. Latin America Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Latin America Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Brazil
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4. Argentina
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5. Rest of Latin America
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 13. MIDDLE EAST Point of Care Testing MARKET BY COUNTRY

13.1. Middle East Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Middle East Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. Saudi Arabia
13.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.4. UAE
13.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.5. Rest of Middle East
13.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 14. AFRICA Point of Care Testing MARKET BY COUNTRY

14.1. Africa Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
14.2. Africa Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
14.3. South Africa
14.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
14.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
14.4. Egypt
14.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
14.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
14.5. Rest of Africa
14.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
14.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 15. COMPANY PROFILE

15.1. Abaxis
15.1.1. Company Snapshot
15.1.2. Overview
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Key Developments
15.1.6. Strategies
15.2. Abbott
15.2.1. Company Snapshot
15.2.2. Overview
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Key Developments
15.2.6. Strategies
15.3. Siemens AG
15.3.1. Company Snapshot
15.3.2. Overview
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Key Developments
15.3.6. Strategies
15.4. F. Hoffmann-La Roche Ltd.
15.4.1. Company Snapshot
15.4.2. Overview
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Key Developments
15.4.6. Strategies
15.5. Johnson and Johnson
15.5.1. Company Snapshot
15.5.2. Overview
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Key Developments
15.5.6. Strategies
15.6. Others
15.6.1. Company Snapshot
15.6.2. Overview
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Key Developments
15.6.6. Strategies

CHAPTER 16. RESEARCH APPROACH

16.1. Research Methodology
16.1.1. Initial Data Search
16.1.2. Secondary Research
16.1.3. Primary Research
16.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1136

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.